ArticleFoods (Basel, Switzerland)2024
Determination of Amino Acids of Novel Food in Food by HPLC Coupled with Pre-Column Derivatization.
Article in Foods (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development of an Analytical Procedure for the Quantification of Artemisinin in Encapsulated Formulations.Foods (Basel, Switzerland) · 2025Article
- Extraction of protein from oilseed meal residues of sesame, hazelnut, almond and pumpkin produced in the oil industry for application in human and animal food.RSC advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A method for simultaneous determination of Theanine and γ-aminobutyric acid (GABA), as the novel food of amino acids, which was established using pre-column derivatization and high-performance liquid chromatography (HPLC). 4-Dimethylaminoazobe nzene-4'-sulfonyl chloride (DABS-Cl) is employed as the derivatization reagent with chromophore linked to Theanine and GABA, which lacks chromophore for DAD analysis in its pristine structure. After the detection wavelength was confirmed, the chromatographic and derivatization conditions were also optimized, including the chromatographic column, mobile phases and their gradient, derivatization temperature and time, the additive amount of buffer solution and derivatization reagent. Methodological verification showed that the derivant of Theanine (DABS-Theanine) and derivant of GABA (DABS-GABA) have good linearity in the range of 1-100 μg/mL, with correlation coefficients of 0.9996 and 0.9995, respectively. The recoveries for both amino acids were between 93.95% and 103.90%, with RSDs ranging from 0.99% to 3.93%. The limit of detection (LOD) was 0.6 mg/kg for Theanine and 0.2 mg/kg for GABA. The limit of quantification (LOQ) was 1.7 mg/kg for Theanine and 0.6 mg/kg for GABA. Furthermore, five commercial products containing Theanine or GABA in two matrices (candy and beverage) were analyzed by the proposed method for validation. The average contents of Theanine and GABA were in the range of 307.49-1312.13 mg/kg and 22.98-6744.55 mg/kg, respectively. The developed method features easy sample pretreatment, a simple derivatization system, good separation specificity, good repeatability, accuracy and reliability, and can meet the large-scale determination Theanine and GABA in various food substrates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.